Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions
about
Oxidative stress associated with neuronal apoptosis in experimental models of epilepsyImmediate Epileptogenesis after Kainate-Induced Status Epilepticus in C57BL/6J Mice: Evidence from Long Term Continuous Video-EEG TelemetryModeling early-onset post-ischemic seizures in aging mice.Advantages of repeated low dose against single high dose of kainate in C57BL/6J mouse model of status epilepticus: behavioral and electroencephalographic studiesEarly-Onset Convulsive Seizures Induced by Brain Hypoxia-Ischemia in Aging Mice: Effects of Anticonvulsive TreatmentsSeizure-induced oxidative stress in temporal lobe epilepsyModels to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agentsEffects of Swimming Exercise on Limbic and Motor Cortex Neurogenesis in the Kainate-Lesion Model of Temporal Lobe EpilepsyA Comparative Toxidrome Analysis of Human Organophosphate and Nerve Agent Poisonings Using Social Media.Effects of chronic administration of gabapentin and carbamazepine on the histomorphology of the hippocampus and striatumMapping epileptic activity: sources or networks for the clinicians?Thymoquinone Attenuates Brain Injury via an Anti-oxidative Pathway in a Status Epilepticus Rat ModelRapid throughput analysis demonstrates that chemicals with distinct seizurogenic mechanisms differentially alter Ca2+ dynamics in networks formed by hippocampal neurons in culture.Montelukast inhibits pentylenetetrazol-induced seizures in ratsReorganization of Basolateral Amygdala-Subiculum Circuitry in Mouse Epilepsy Model.Status epilepticus: Using antioxidant agents as alternative therapies.Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.Lithium chloride could aggravate brain injury caused by 3-nitropropionic acid.Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures.Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.Prospects of modeling poststroke epileptogenesis.Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus.The Repeated Flurothyl Seizure Model in Mice.Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.Consequences of status epilepticus in the intensive care unit: what we know and what we need to knowHungry Neurons: Metabolic Insights on Seizure Dynamics.Development and pharmacologic characterization of the rat 6 Hz model of partial seizures.Neuroprotective effects of vitamin D alone or in combination with lamotrigine against lithium-pilocarpine model of status epilepticus in rats.DNA damage and oxidative stress induced by seizures are decreased by anticonvulsant and neuroprotective effects of lobeline, a candidate to treat alcoholism.Effect of Liraglutide on Corneal Kindling Epilepsy Induced Depression and Cognitive Impairment in Mice.Synergistic anticonvulsant effects of pregabalin and amlodipine on acute seizure model of epilepsy in mice.Melatonin Alleviates the Epilepsy-Associated Impairments in Hippocampal LTP and Spatial Learning Through Rescue of Surface GluR2 Expression at Hippocampal CA1 Synapses.Status Epilepticus: Behavioral and Electroencephalography Seizure Correlates in Kainate Experimental Models.Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy.Mice with conditional NeuroD1 knockout display reduced aberrant hippocampal neurogenesis but no change in epileptic seizures.Early metabolic responses to lithium/pilocarpine-induced status epilepticus in rat brain.Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model.Sodium valproate compared to phenytoin in treatment of status epilepticus.The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy.
P2860
Q26823122-EC7892F4-689F-42B5-87A9-471BA833AF04Q27303313-91D3F85E-3B94-4A3D-91CF-68B5F5CE020EQ27311362-DF6EC99F-DBEA-42F7-9768-3280DD194C28Q27334351-906740BE-9670-4758-BEBD-CCC871DD8F8AQ27336213-410AE601-216D-49A1-9A51-2104D2AF4AACQ27692712-F82E0D24-E33B-4E79-8332-8187970A3175Q28391535-CCD397D2-190F-4F40-8C2B-9D5E5B5AAF21Q28829124-B43B465A-9CEC-4A03-8629-8E71D5C5D5CFQ30151312-77E2CFDB-ABA2-4BCB-BDA0-FB4150F425C2Q33980101-697E9E6A-D94A-4988-8147-AFD894FB8355Q34454826-57C27811-AD5A-4286-BCCA-88449F8E33E2Q34555111-65923231-80A6-4D0F-947E-AC460B866FA3Q35198051-C388D3B9-739F-4F48-A113-6FE7BB8A12CAQ35259497-9799F04E-155A-4A00-95F6-EB42AFCE51C7Q36460700-1AB71087-AB66-48D8-9827-F98BA9E07197Q37288222-E557F76B-2BE9-4ADF-AF38-B71400DB5452Q37320505-6FBF166A-FD86-4824-8BC0-4182236ED143Q37471801-0C203812-A937-489B-B9E5-6DC441D6CDE4Q37597272-044CA90C-31D3-4434-83F9-0A6F221C8A95Q38684428-E8562061-803D-4F08-9941-BA7DF83E9E33Q38906926-6CE53100-DC44-4283-89ED-0FFB40E250EEQ39126886-9E9A686D-A7B4-48BC-935F-A66D727AA1E2Q40219466-820A70AC-8C99-4326-886B-24DF3D7DB369Q41104726-9C4320C9-1029-412B-9F23-195B45F523B5Q42581871-BE0CAE47-A311-47CE-AFA2-3D5B0E007121Q42688868-3F448E66-F331-4F3C-9555-54B5D983AAECQ46260481-031464E0-99B6-4AD8-81A0-28CB153130C3Q46375658-CF4CD40E-0152-4BAD-BC1E-4F38322C9313Q47979564-333A6C46-A9B9-467F-B8FB-505ED6AD2F90Q48018449-63D96D94-370A-41F2-AEEC-1C00B8B634B0Q48059966-CF140DDF-74D0-4518-9C5D-898C260BF958Q48269990-75CF8BBF-B5BF-43B1-9666-4BB034F82E3CQ48302540-4D705232-3F93-42D2-836C-80E7B7C08CB3Q49310896-9ABDD991-6BBE-4F94-B2F6-409AF59D2989Q49347037-2BA978E2-215F-44D5-A063-AAB5D17F3CF7Q51044269-60427B59-B859-4680-90BD-72AC290B385FQ52149350-5C7AB963-4C09-44EF-BD7B-9AEE89A4C5BFQ54967844-8C5E603E-8970-4D12-B602-898D74B2A536Q54983720-D82D86E9-2D04-49E4-8221-AD2D264C3109Q55137379-4B4789D0-277A-4710-A600-FD977BB2608B
P2860
Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Experimental models of status ...... n of therapeutic interventions
@en
Experimental models of status ...... of therapeutic interventions.
@nl
type
label
Experimental models of status ...... n of therapeutic interventions
@en
Experimental models of status ...... of therapeutic interventions.
@nl
prefLabel
Experimental models of status ...... n of therapeutic interventions
@en
Experimental models of status ...... of therapeutic interventions.
@nl
P2860
P356
P1476
Experimental models of status ...... n of therapeutic interventions
@en
P2093
Ramkumar Kuruba
P2860
P304
18284-18318
P356
10.3390/IJMS140918284
P407
P50
P5008
P577
2013-09-05T00:00:00Z